enow.com Web Search

  1. Ads

    related to: pamrevlumab

Search results

  1. Results from the WOW.Com Content Network
  2. Pamrevlumab - Wikipedia

    en.wikipedia.org/wiki/Pamrevlumab

    Pamrevlumab (INN; [1] development code FG-3019) is a humanized monoclonal antibody designed for the treatment of idiopathic pulmonary fibrosis and pancreatic cancer. It binds to the connective tissue growth factor (CTGF) protein.

  3. Emapalumab - Wikipedia

    en.wikipedia.org/wiki/Emapalumab

    Emapalumab, sold under the brand name Gamifant, is an anti-interferon-gamma (IFNγ) antibody medication used for the treatment of hemophagocytic lymphohistiocytosis (HLH), [3] [4] [5] which has no cure.

  4. Mavrilimumab - Wikipedia

    en.wikipedia.org/wiki/Mavrilimumab

    Mavrilimumab is a human monoclonal antibody [1] that inhibits human granulocyte macrophage colony-stimulating factor receptor (GM-CSF-R). [2]Mavrilimumab was discovered as CAM-3001 by Cambridge Antibody Technology and is being developed by MedImmune, Inc. [1] as an investigational drug for the treatment of rheumatoid arthritis

  5. Nivolumab - Wikipedia

    en.wikipedia.org/wiki/Nivolumab

    Nivolumab, sold under the brand name Opdivo, is an anti-cancer medication used to treat a number of types of cancer. [2] This includes melanoma, lung cancer, malignant pleural mesothelioma, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, urothelial carcinoma, colon cancer, esophageal squamous cell carcinoma, liver cancer, gastric cancer, and esophageal or gastroesophageal ...

  6. Durvalumab - Wikipedia

    en.wikipedia.org/wiki/Durvalumab

    The US Food and Drug Administration (FDA) approved durvalumab for certain types of bladder, lung, and biliary tract cancer: [6] [13] [14]. Adults with locally advanced or metastatic urothelial carcinoma who either have disease progression during or following platinum-containing chemotherapy or have disease progression within twelve months of neoadjuvant or adjuvant treatment with platinum ...

  7. Urelumab - Wikipedia

    en.wikipedia.org/wiki/Urelumab

    Urelumab (BMS-663513 or anti-4-1BB antibody) is a fully human, non‐ligand binding, CD137 agonist immunoglobulin‐γ 4 (IgG4) monoclonal antibody. [1] It was developed utilizing Medarex's UltiMAb(R) technology by Bristol-Myers Squibb for the treatment of cancer and solid tumors. [2]

  8. Tocilizumab - Wikipedia

    en.wikipedia.org/wiki/Tocilizumab

    Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, COVID‑19, and systemic sclerosis-associated interstitial lung disease (SSc-ILD).

  9. Relatlimab - Wikipedia

    en.wikipedia.org/wiki/Relatlimab

    This monoclonal antibody –related article is a stub. You can help Wikipedia by expanding it.

  1. Ads

    related to: pamrevlumab